maps glp 1 The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Structural and Functional Diversity among

GLP-1 medications such as Wegovy, Ozempic, Zepbound, Mounjaro, and Saxenda have transformed obesity treatment

Research in animal models indicates that GLP-1 receptor agonists reduce self-administration of cocaine, nicotine, and alcohol by modulating dopamine signaling (Egecioglu et al., 2013

What Pfizer says about Phase 3 in 2026 Pfizer plans to advance 10 Phase 3 studies for berobenatide in 2026, within a broader 20+ trial program for obesity and related comorbidities

In a related study, iron oxide NPs coated with M1 macrophage membranes (IO@MM) were engineered as an immunotherapeutic strategy for lung-metastatic colorectal cancer